Hartford Funds Management’s Labcorp LH Stock Holding History

Hartford Funds Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,284	Closed	-$253K	–	93
2023 Q1	$253K	Buy	1,284 +32	+3%	+$6.58K	0.03%	75
2022 Q4	$253K	Buy	+1,252	New	+$245K	0.03%	54

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Hartford Funds Management's LH Position: Q2 2023 in Review

Hartford Funds Management sold out of Labcorp (LH) in Q2 2023, closing a stake of 1,284 shares — an estimated $253K sold.

Hartford Funds Management first reported a position in LH in Q4 2022 and held it in 2 quarters. The position peaked at $253K in Q4 2022. 932 funds tracked by Wall St. Rank hold LH as of Q2 2023.

Hartford Funds Management reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
Hartford Funds Management sold 1,284 Labcorp shares in Q2 2023, an estimated $253K.
Hartford Funds Management first reported a position in Labcorp in Q4 2022 and held it in 2 quarters.
Hartford Funds Management's Labcorp position peaked at $253K in Q4 2022.
932 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.

Based on Hartford Funds Management's 13F filing for Q2 2023, filed 4 Aug 2023.